Pharma companies asked to reduce pricesDecember 15th, 2008 - 6:21 pm ICT by IANS
New Delhi, Dec 15 (IANS) The National Pharmaceutical Pricing Authority (NPPA) Monday asked pharmaceutical companies to reduce prices by 2.84 percent following a cut in excise duty on medicine.The NPPA, a government agency set up to check selling of drugs at exorbitant prices, had recently cut excise duty on medicines from 8 percent to 4 percent.
It has now asked all pharma manufacturers to ensure that the benefit of the excise duty reduction and the reduced rate of abatement is passed on to the consumers by lowering the retail price of their products.
Abatement is the reduction in benefit payments when additional income is being earned through work.
The NPPA decision is expected to impact major pharma giants such as GlaxoSmithKline, Roche, Eli Lilly and Pfizer, among others.
When contacted, a senior NPPA official said there exists a huge differences in prices of imported drugs and those produced by domestic firms.
Most imported drugs come under the category of prescription-based sales, making their prices higher than those of the local variants, the official added.
- Pharma bigwigs join hands for new TB drug - Jun 27, 2012
- Swine flu jab under scrutiny over dangerous sleep disorder fears - Aug 28, 2010
- FDA Adds A Warning About Liver Deterioration On Weight Loss Pills - May 27, 2010
- Pfizer snaps insulin marketing deal with Biocon - Mar 13, 2012
- Abbott Labs pays 3.7 bn dollars to buy into Mumbai's Piramal Healthcare - May 22, 2010
- Asthama Drugs Get New FDA Regulations - Feb 19, 2010
- Diabetes drug increases heart attack risks, say experts - Sep 06, 2010
- Prior price approval mandatory for scheduled drugs - Jul 30, 2010
- GlaxoSmithKline to cut 6,000 jobs - Feb 02, 2009
- French Man Claims GlaxoSmithKline Drug Made Him Gay Sex Addict - Feb 01, 2011
- Man claims Glaxo drug made him a 'gay sex addict' - Feb 01, 2011
- Public not to be hit if Natco Pharma licence cancelled: Bayer - Sep 03, 2012
- Weight Loss Pills 'Alli' & 'Xenical' Get FDA Liver Damage Warning! - May 27, 2010
- GlaxoSmithKline to go public with malaria data - Jan 20, 2010
- No need to revise fiscal deficit target: Pranab - Jul 05, 2011